Database Query Results : , ,
Hepat, Hepatoma: Click to Expand ⟱
Hepatoma: usually malignant tumor occurring in the liver.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Hepat, |
HepG2 |
|
|
|
GSH↓, Apoptosis↑, Bcl-2↓, cMyc↓,
| - |
vitro+vivo, |
HCC, |
HepG2 |
|
|
|
- |
in-vitro, |
HCC, |
Hep3B |
|
|
|
- |
in-vitro, |
HCC, |
HUH7 |
|
|
|
- |
vitro+vivo, |
Hepat, |
SK-HEP-1 |
|
|
|
SREBF2↓, Akt↓, TumCCA↑, TumCG↓, STAT3↓,
DNAdamC↑, Casp1↑,
| - |
in-vitro, |
Hepat, |
HepG2 |
|
|
|
- |
in-vitro, |
Hepat, |
WI38 |
|
|
|
TNF-α↑, IL33↑, mTOR↓, MMP9↓, Bcl-2↓, ROS↑, Apoptosis↑,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Hepat, |
HepG2 |
|
|
|
- |
in-vitro, |
CRC, |
SW-620 |
|
|
|
TumCD↑,
ROS↑, GlucoseCon↓, TumCD↑, NRF2↓,
NRF2↑, GSH↓,
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 7
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
GSH↓, 2, NRF2↓, 1, NRF2↑, 1, ROS↑, 2,
Core Metabolism/Glycolysis ⓘ
cMyc↓, 1, GlucoseCon↓, 1, SREBF2↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 2, Bcl-2↓, 2, Casp1↑, 1, TumCD↑, 2,
DNA Damage & Repair ⓘ
DNAdamC↑, 1,
Cell Cycle & Senescence ⓘ
TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
mTOR↓, 1, STAT3↓, 1, TumCG↓, 1,
Migration ⓘ
MMP9↓, 1,
Immune & Inflammatory Signaling ⓘ
IL33↑, 1, TNF-α↑, 1,
Total Targets: 20
Pathway results for Effect on Normal Cells:
Total Targets: 0
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:11 Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page